Rufinamide

Chemical formula: C₁₀H₈F₂N₄O  Molecular mass: 238.194 g/mol  PubChem compound: 129228

Active ingredient description

Rufinamide is an anticonvulsant medication. Rufinamide modulates the activity of sodium channels, prolonging their inactive state.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code Group title Classification
N03AF03 Rufinamide N Nervous system → N03 Antiepileptics → N03A Antiepileptics → N03AF Carboxamide derivatives
Discover more medicines within N03AF03

Product monographs

Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):

Title Information Source Document Type  
INOVELON Film-coated tablet European Medicines Agency (EU) MPI, EU: SmPC
BANZEL Film-coated tablet / Oral suspension FDA, National Drug Code (US) MPI, US: SPL/PLR

Structural formula

Graphic representation of the active ingredient's molecular structure

External identifiers

CAS Substance: 106308-44-5
DrugBank Drug: DB06201
KEGG Drug: D05775
PubChem Compound: 129228
RxNorm Ingredient: 69036
SNOMED-CT Concept: 429835003
Rufinamide (substance)
UNII Identifier: WFW942PR79
RUFINAMIDE

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.